Renaissance Technologies’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$66M Sell
71,788
-94,059
-57% -$95.4M 0.1% 245
2025
Q4
$178M Buy
+165,847
New +$159M 0.28% 69
2025
Q3
Sell
-261
Closed -$205K 3738
2025
Q2
$205K Sell
261
-96,051
-100% -$74.6M ﹤0.01% 3166
2025
Q1
$79.5M Buy
96,312
+42,192
+78% +$35.1M 0.12% 201
2024
Q4
$41.8M Sell
54,120
-203,693
-79% -$169M 0.06% 382
2024
Q3
$228M Buy
+257,813
New +$232M 0.34% 43
2024
Q2
Sell
-130,178
Closed -$101M 3771
2024
Q1
$101M Sell
130,178
-143,685
-52% -$102M 0.16% 134
2023
Q4
$160M Buy
273,863
+138,399
+102% +$80.8M 0.25% 76
2023
Q3
$72.8M Buy
135,464
+122,455
+941% +$63.1M 0.12% 174
2023
Q2
$6.1M Sell
13,009
-440,571
-97% -$185M 0.01% 1313
2023
Q1
$156M Sell
453,580
-319,774
-41% -$108M 0.21% 94
2022
Q4
$283M Sell
773,354
-241,293
-24% -$85.6M 0.39% 34
2022
Q3
$328M Buy
1,014,647
+613,764
+153% +$194M 0.46% 27
2022
Q2
$130M Buy
400,883
+297,183
+287% +$89.2M 0.15% 140
2022
Q1
$29.7M Sell
103,700
-90,247
-47% -$23.2M 0.03% 545
2021
Q4
$53.6M Sell
193,947
-859,500
-82% -$218M 0.07% 317
2021
Q3
$243M Buy
1,053,447
+967,347
+1,124% +$239M 0.31% 61
2021
Q2
$19.8M Sell
86,100
-146,847
-63% -$29.5M 0.02% 761
2021
Q1
$43.5M Buy
+232,947
New +$45.6M 0.05% 405
2020
Q4
Sell
-481,547
Closed -$71.3M 3576
2020
Q3
$71.3M Sell
481,547
-132,400
-22% -$20.5M 0.07% 286
2020
Q2
$101M Buy
613,947
+399,347
+186% +$61.3M 0.09% 241
2020
Q1
$29.8M Buy
+214,600
New +$29.5M 0.03% 582
2019
Q4
Sell
-162,699
Closed -$18.2M 3639
2019
Q3
$18.2M Sell
162,699
-2,145,902
-93% -$239M 0.02% 1014
2019
Q2
$256M Buy
2,308,601
+1,583,947
+219% +$187M 0.23% 93
2019
Q1
$94M Buy
724,654
+713,854
+6,610% +$86.8M 0.09% 272
2018
Q4
$1.25M Buy
+10,800
New +$1.21M ﹤0.01% 2470
2018
Q3
Sell
-488,000
Closed -$41.6M 3464
2018
Q2
$41.6M Sell
488,000
-3,267,705
-87% -$268M 0.05% 524
2018
Q1
$291M Sell
3,755,705
-516,400
-12% -$41.6M 0.32% 40
2017
Q4
$361M Buy
4,272,105
+222,900
+6% +$19M 0.4% 32
2017
Q3
$346M Sell
4,049,205
-1,645,700
-29% -$135M 0.41% 27
2017
Q2
$469M Buy
5,694,905
+2,714,505
+91% +$221M 0.6% 15
2017
Q1
$251M Buy
2,980,400
+1,441,200
+94% +$115M 0.35% 36
2016
Q4
$113M Buy
1,539,200
+617,000
+67% +$45.9M 0.18% 100
2016
Q3
$74M Sell
922,200
-1,269,005
-58% -$102M 0.13% 167
2016
Q2
$173M Sell
2,191,205
-22,400
-1% -$1.69M 0.33% 31
2016
Q1
$159M Buy
2,213,605
+1,880,800
+565% +$142M 0.3% 40
2015
Q4
$28M Buy
332,805
+111,800
+51% +$9.28M 0.06% 383
2015
Q3
$18.5M Buy
+221,005
New +$18.7M 0.04% 537
2015
Q2
Sell
-418,805
Closed -$30.4M 3299
2015
Q1
$30.4M Sell
418,805
-404,395
-49% -$28.8M 0.06% 394
2014
Q4
$56.8M Sell
823,200
-940,700
-53% -$63.5M 0.14% 149
2014
Q3
$114M Sell
1,763,900
-1,578,100
-47% -$99.9M 0.31% 38
2014
Q2
$208M Sell
3,342,000
-1,914,105
-36% -$114M 0.48% 23
2014
Q1
$309M Sell
5,256,105
-1,805,595
-26% -$101M 0.74% 13
2013
Q4
$360M Sell
7,061,700
-1,226,105
-15% -$61.4M 0.86% 8
2013
Q3
$417M Sell
8,287,805
-4,038,400
-33% -$211M 1.01% 7
2013
Q2
$605M Buy
+12,326,205
New +$671M 1.59% 2

Other funds holding LLY

Renaissance Technologies's LLY Position: Q1 2026 in Review

Renaissance Technologies reduced its Eli Lilly (LLY) stake by 57% in Q1 2026, selling an estimated $95.4M and leaving 71,788 shares worth $66M. The position accounts for 0.1% of the portfolio, ranked #245.

Renaissance Technologies first reported a position in LLY in Q2 2013 and has held it in 46 quarters since. The position peaked at $605M in Q2 2013. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Renaissance Technologies held 71,788 shares of Eli Lilly worth $66M as of Q1 2026.
  • Renaissance Technologies sold 94,059 Eli Lilly shares in Q1 2026, an estimated $95.4M.
  • Eli Lilly made up 0.1% of Renaissance Technologies's portfolio in Q1 2026, its #245 holding.
  • Renaissance Technologies first reported a position in Eli Lilly in Q2 2013 and has held it in 46 quarters since.
  • Renaissance Technologies's Eli Lilly position peaked at $605M in Q2 2013.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.